Ebola outbreak in Congo expands as WHO warns of growing cross-border risk.

The Ebola outbreak in the Democratic Republic of the Congo is continuing to expand geographically, with the World Health Organization warning that the growing number of affected areas is increasing the risk of transmission across international borders.

The outbreak is caused by Bundibugyo virus, a less common species of Ebola for which there is currently no licensed vaccine or specific antiviral treatment approved for routine use. First detected in the Democratic Republic of the Congo in May, the outbreak has become the largest Ebola outbreak ever recorded in the country and has continued to spread despite intensified surveillance and response efforts.

According to the latest WHO update published on September 25, cases have now been detected in 63 health zones across seven of the country’s 26 provinces. The two most recent affected areas are Bulu, in Sud-Ubangi province in the northwest, and Dungu, in Haut-Uélé province near the border with South Sudan.

As of September 23, the Democratic Republic of the Congo had recorded 7,890 confirmed cases and 3,799 deaths. The crude case fatality ratio stood at 48.1%.

The figures underline both the scale of the outbreak and the difficulty of containing transmission in a country where some affected communities are remote, healthcare access is limited and population movements remain substantial.

The outbreak is no longer concentrated in one part of the country

When the outbreak was first identified, transmission was largely concentrated in Ituri province in northeastern Congo.

Ituri remains the main centre of the epidemic, but the geographic pattern has changed considerably. Cases have spread into North Kivu, Haut-Uélé, Tshopo, Bas-Uélé, South Kivu and, more recently, Sud-Ubangi.

The expansion into Sud-Ubangi is particularly significant because the province borders both the Central African Republic and the Republic of the Congo. The appearance of cases in Dungu, meanwhile, places the outbreak closer to South Sudan.

WHO has warned that this geographic expansion increases the possibility of the virus reaching neighbouring countries through population movements, trade and other forms of cross-border activity.

The organisation has classified the risk inside the Democratic Republic of the Congo as very high. For countries sharing a land border with the country, the risk remains high.

The assessment for the rest of Africa and for the world as a whole remains low.

Cross-border movement is a central concern

The geography of the outbreak creates particular challenges for health authorities.

People regularly cross borders in the region for trade, employment, mining and family reasons. Some movement also takes place through informal crossing points that are difficult for authorities to monitor.

WHO says screening and surveillance measures are operating at airports, ports and official land border crossings. However, informal routes can allow people to move between countries without being screened.

This does not mean that international transmission is inevitable.

It does mean that an infected person who has not been identified can potentially reach another country before symptoms are recognised, creating additional work for health authorities trying to trace contacts and identify new cases.

Uganda has already recorded confirmed Bundibugyo virus cases linked to the outbreak in the Democratic Republic of the Congo. WHO’s latest cumulative figures include 20 confirmed cases in Uganda.

That experience is one reason the organisation is placing such strong emphasis on cross-border coordination.

Why Bundibugyo virus presents a particular challenge

The current outbreak is not caused by the Zaire species of Ebola, which is the virus most commonly associated with some of the largest Ebola outbreaks in recent decades.

It involves Bundibugyo virus, a different Ebola species.

That distinction matters because medical tools developed against one Ebola virus cannot automatically be assumed to provide the same protection against another.

The Ervebo vaccine, for example, is licensed for protection against Zaire ebolavirus. WHO says there is currently insufficient evidence to establish its effectiveness against Bundibugyo virus in humans.

For that reason, WHO’s current recommendation is that Ervebo be used against Bundibugyo virus within the context of a research protocol rather than as a routine vaccination programme.

At the same time, vaccination of healthcare and frontline workers has begun as part of the response and research effort. More than 2,000 people had received vaccinations by early September, according to WHO.

The lack of a proven vaccine specifically for Bundibugyo virus makes early detection, isolation, infection prevention and supportive medical care particularly important.

Delayed diagnosis remains one of the biggest problems

Ebola is difficult to contain when cases are detected late.

The virus is primarily transmitted through direct contact with an infected person’s blood or other bodily fluids. Transmission can also occur through contact with the bodies of people who have died from the disease.

That means healthcare facilities, households and communities can all become points of transmission when cases are not identified quickly.

WHO says delays in detecting cases are contributing to continued transmission in households, communities and healthcare settings.

In the Democratic Republic of the Congo, the problem is made more difficult by insecurity and population displacement.

Some affected areas have limited access to healthcare facilities, while overcrowded communities, informal settlements and displaced-person sites can make infection prevention more difficult.

Mining communities are another concern because they can bring together large numbers of people from different areas, creating additional opportunities for the virus to move between communities.

The humanitarian situation makes containment harder

The Ebola outbreak is unfolding against an already difficult humanitarian background.

Parts of eastern Congo have experienced prolonged insecurity and displacement, complicating the work of health teams attempting to investigate cases and trace contacts.

When healthcare workers cannot safely reach an affected community, the response becomes slower.

That can affect almost every stage of outbreak control: finding people who may have been exposed, testing suspected cases, isolating infected patients, monitoring contacts and communicating health guidance to local communities.

WHO and its partners are therefore working on more than clinical treatment.

The response includes surveillance, laboratory testing, infection prevention, community engagement, contact tracing and the establishment of treatment and isolation facilities close to affected communities.

The organisation says cross-border collaboration is also being strengthened through surveillance at border points, information sharing, rapid alerts and preparedness exercises.

There is still no reason for broad travel restrictions

Despite the expansion of the outbreak, WHO is not recommending general restrictions on international travel or trade.

The organisation’s position is that blanket travel restrictions are not justified by the current global risk assessment.

There is also a practical consideration. Closing official borders can encourage people to use informal crossing routes that are harder to monitor.

For health authorities, knowing where people are travelling and being able to identify potential contacts can be more useful than simply restricting movement.

The focus therefore remains on targeted surveillance, rapid detection and cooperation between neighbouring countries.

Research is becoming an important part of the response

Because Bundibugyo virus is relatively uncommon, the current outbreak is also providing an opportunity to generate evidence that could improve future responses.

A clinical trial investigating potential treatments began enrolling patients in July in Ituri province. WHO has also been working with researchers on the question of whether existing Ebola vaccines could provide protection against Bundibugyo virus.

This research is particularly important because treatment options are currently limited.

Supportive medical care can improve outcomes, especially when patients are diagnosed early and receive appropriate treatment. But the absence of a specific approved antiviral therapy for this virus makes prevention and early intervention even more important.

The experience could also influence how health authorities respond to future outbreaks involving less common Ebola species.

The risk beyond Congo remains limited, but vigilance is essential

The WHO’s latest assessment contains an important distinction.

The outbreak is a serious regional health threat, but it is not currently assessed as a high global risk.

The highest level of concern remains inside the Democratic Republic of the Congo, where transmission is extensive and continues to reach new areas. Countries sharing land borders with the country face a higher risk because of geographic proximity and population mobility.

For the rest of Africa and the global population, WHO currently assesses the risk as low.

That assessment is based on the information available to health authorities and can change if the epidemiological situation changes.

For now, the priority is preventing local transmission from becoming wider regional transmission.

A race against geographic expansion

The latest developments show why the speed of the response matters.

The outbreak has moved from one initially concentrated area to dozens of health zones across seven provinces. Each new geographic expansion creates additional demands on surveillance teams, laboratories, hospitals and local health authorities.

The challenge is especially difficult in communities where insecurity, limited infrastructure and population movements make conventional outbreak-control measures harder to implement.

The Democratic Republic of the Congo has extensive experience responding to Ebola outbreaks, and international organisations have built substantial expertise in surveillance, treatment and community engagement.

But the scale and geographic reach of the current Bundibugyo outbreak are testing that capacity.

For neighbouring countries, the priority is to strengthen preparedness before imported cases appear, rather than waiting for transmission to become established.

And for the international health community, the situation remains a reminder that infectious disease risks are rarely confined by political borders.

The latest figures do not indicate an uncontrolled global spread of Ebola. They do show a persistent and geographically expanding outbreak in central Africa that requires sustained international attention.

The immediate objective is therefore clear: detect cases earlier, protect healthcare workers, improve access to care and prevent the virus from following people across borders into communities that are not yet affected.

Sources: World Health Organization, WHO Regional Office for Africa, WHO Disease Outbreak News, The Lancet Infectious Diseases